PAK4 promotes kinase-independent stabilization of RhoU to modulate cell adhesion
Open Access
- 23 November 2015
- journal article
- research article
- Published by Rockefeller University Press in Journal of Cell Biology
- Vol. 211 (4) , 863-879
Abstract
P21-activated kinase 4 (PAK4) is a Cdc42 effector protein thought to regulate cell adhesion disassembly in a kinase-dependent manner. We found that PAK4 expression is significantly higher in high-grade human breast cancer patient samples, whereas depletion of PAK4 modifies cell adhesion dynamics of breast cancer cells. Surprisingly, systematic analysis of PAK4 functionality revealed that PAK4-driven adhesion turnover is neither dependent on Cdc42 binding nor kinase activity. Rather, reduced expression of PAK4 leads to a concomitant loss of RhoU expression. We report that RhoU is targeted for ubiquitination by the Rab40A–Cullin 5 complex and demonstrate that PAK4 protects RhoU from ubiquitination in a kinase-independent manner. Overexpression of RhoU rescues the PAK4 depletion phenotype, whereas loss of RhoU expression reduces cell adhesion turnover and migration. These data support a new kinase-independent mechanism for PAK4 function, where an important role of PAK4 in cellular adhesions is to stabilize RhoU protein levels. Thus, PAK4 and RhoU cooperate to drive adhesion turnover and promote cell migration.Keywords
This publication has 63 references indexed in Scilit:
- Proteomic Analyses Reveal Divergent Ubiquitylation Site Patterns in Murine TissuesMolecular & Cellular Proteomics, 2012
- Type II p21-activated kinases (PAKs) are regulated by an autoinhibitory pseudosubstrateProceedings of the National Academy of Sciences, 2012
- SHARPIN is an endogenous inhibitor of β1-integrin activationNature Cell Biology, 2011
- p21-activated kinase 4 regulates ovarian cancer cell proliferation, migration, and invasion and contributes to poor prognosis in patientsProceedings of the National Academy of Sciences, 2010
- The protein kinase Pak4 disrupts mammary acinar architecture and promotes mammary tumorigenesisOncogene, 2010
- Small-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growthProceedings of the National Academy of Sciences, 2010
- Chromosomal changes in aggressive breast cancers with basal-like featuresCancer Genetics and Cytogenetics, 2009
- The RhoU/Wrch1 Rho GTPase gene is a common transcriptional target of both the gp130/STAT3 and Wnt-1 pathwaysBiochemical Journal, 2009
- XRab40 and XCullin5 form a ubiquitin ligase complex essential for the noncanonical Wnt pathwayThe EMBO Journal, 2007
- A collection of breast cancer cell lines for the study of functionally distinct cancer subtypesCancer Cell, 2006